Clinical Impact of Hospital-Acquired Anemia in Association with Acute Kidney Injury and Chronic Kidney Disease in Patients with Acute Myocardial Infarction
Background Hospital-acquired anemia (HAA) is common in patients with acute myocardial infarction (AMI) and is an independent indicator of long-term mortality in these patients. However, limited information exists regarding the development and prognostic impact of HAA associated with acute kidney injury (AKI) and chronic kidney disease (CKD) in AMI patients. Methods and Results We retrospectively analyzed 2,289 patients with AMI, and excluded those with anemia at admission. The study population included 1,368 patients, of whom 800 (58.5%) developed HAA. Age, Hgb level at admission, Length of hospital stay, documented in-hospital bleeding and use of glycoprotein IIb/IIIa inhibitor, presence of CKD and occurrence of AKI were significantly associated with the development of HAA. HAA was significantly associated with higher 3-year mortality (4.8% and 11.4% for non-HAA and HAA patients, respectively; P < 0.001). After adjustment for multivariable confounders, the risk for long-term mortality was increased in HAA patients with AKI and/or CKD but not in HAA patients without AKI and/or CKD, compared to non-HAA patients (HAA patients without AKI and CKD, hazard ratio [HR]: 1.34, 95% confidence interval [CI]: 0.70–2.56; HAA patients with either AKI or CKD, HR: 2.80, 95% CI: 1.37–5.73; HAA patients with AKI and CKD, HR: 3.25, 95% CI: 1.28–8.24; compared with the non-HAA group). Conclusion AKI and CKD were strongly associated with the development of HAA in AMI patients. HAA, when accompanied by AKI or CKD, is an independent risk predictor for long-term mortality in AMI patients.
References
[1]
Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM (2001) Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345: 1230-1236. doi:10.1056/NEJMoa010615. PubMed: 11680442.
[2]
Langston RD, Presley R, Flanders WD, McClellan WM (2003) Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 64: 1398-1405. doi:10.1046/j.1523-1755.2003.00200.x. PubMed: 12969159.
[3]
Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA et al. (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111: 2042-2049. doi:10.1161/01.CIR.0000162477.70955.5F. PubMed: 15824203.
[4]
Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R et al. (2002) Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 144: 636-641. doi:10.1016/S0002-8703(02)00134-5. PubMed: 12360159.
[5]
Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS et al. (2010) Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 3: 337-346. doi:10.1161/CIRCOUTCOMES.110.957050. PubMed: 20488919.
[6]
Salisbury AC, Amin AP, Reid KJ, Wang TY, Masoudi FA et al. (2011) Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction. Am Heart J 162: 300-309 e303 doi:10.1016/j.ahj.2011.05.021. PubMed: 21835291.
[7]
Tahnk-Johnson ME, Sharkey SW (1993) Impact of thrombolytic therapy on hemoglobin change after acute myocardial infarction. Am J Cardiol 71: 869-872. doi:10.1016/0002-9149(93)90842-Z. PubMed: 8456772.
[8]
McGonigle RJ, Wallin JD, Shadduck RK, Fisher JW (1984) Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 25: 437-444. doi:10.1038/ki.1984.36. PubMed: 6727139.
Cotes PM (1982) Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol 50: 427-438.
[11]
Erslev AJ, Besarab A (1997) Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 51: 622-630. doi:10.1038/ki.1997.91. PubMed: 9067892.
Nielsen OJ, Thaysen JH (1990) Erythropoietin deficiency in acute tubular necrosis. J Intern Med 227: 373-380. doi:10.1111/j.1365-2796.1990.tb00175.x. PubMed: 2351924.
[14]
Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME et al. (1982) Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. J Lab Clin Med 99: 624-635. PubMed: 7069267.
[15]
Davies MJ (1997) The composition of coronary-artery plaques. N Engl J Med 336: 1312-1314. doi:10.1056/NEJM199705013361809. PubMed: 9113937.
[16]
Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377-381. doi:10.1136/hrt.69.5.377. PubMed: 8518056.
[17]
Montalescot G, Dallongeville J, Van Belle E, Rouanet S, Baulac C et al. (2007) STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28: 1409-1417. PubMed: 17412730.
[18]
Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36: 959-969. doi:10.1016/S0735-1097(00)00804-4. PubMed: 10987628.
[19]
(1968) Nutritional anaemias. Report of a WHO scientific group. WHO Tech Rep Ser 405: 5-37.
[20]
(2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int: S1-S138.
[21]
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266. doi:10.1016/S0272-6386(02)70055-3. PubMed: 11904577.
[22]
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612. doi:10.7326/0003-4819-150-9-200905050-00006. PubMed: 19414839.
[23]
Salisbury AC, Kosiborod M, Amin AP, Reid KJ, Alexander KP et al. (2011) Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. Am J Cardiol 108: 949-954. doi:10.1016/j.amjcard.2011.05.026. PubMed: 21784387.
[24]
Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23: 1631-1634. doi:10.1681/ASN.2011111078. PubMed: 22935483.
[25]
du Cheyron D, Parienti JJ, Fekih-Hassen M, Daubin C, Charbonneau P (2005) Impact of anemia on outcome in critically ill patients with severe acute renal failure. Intensive Care Med 31: 1529-1536. doi:10.1007/s00134-005-2739-5. PubMed: 16205892.
[26]
Hales M, Solez K, Kjellstrand C (1994) The anemia of acute renal failure: association with oliguria and elevated blood urea. Ren Fail 16: 125-131. doi:10.3109/08860229409044854. PubMed: 8184139.
[27]
Alfaleh HF, Alsuwaida AO, Ullah A, Hersi A, Alhabib KF et al. (2013) The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome. Int J Cardiol, 167: 866–70. PubMed: 22349044.
[28]
Amin AP, Spertus JA, Reid KJ, Lan X, Buchanan DM et al. (2010) The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J 160: 1065-1071. doi:10.1016/j.ahj.2010.08.007. PubMed: 21146659.
[29]
Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295. doi:10.1056/NEJMoa041365. PubMed: 15385655.
[30]
Bae EH, Lim SY, Cho KH, Choi JS, Kim CS et al. (2012) GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 59: 795-802. doi:10.1053/j.ajkd.2012.01.016. PubMed: 22445708.
[31]
Anand I, McMurray JJ, Whitmore J, Warren M, Pham A et al. (2004) Anemia and its relationship to clinical outcome in heart failure. Circulation 110: 149-154. doi:10.1161/01.CIR.0000134279.79571.73. PubMed: 15210591.
[32]
O’Riordan E, Foley RN (2000) Effects of anaemia on cardiovascular status. Nephrol Dial Transplant 15 (Suppl 3): 19-22. doi:10.1093/oxfordjournals.ndt.a027971. PubMed: 11032353.
